Volume III: Laminitis, Hoof Tissue and Inflammation

Volume III: Laminitis, Hoof Tissue and Inflammation

Volume III: Laminitis, Hoof Tissue and Inflammation

Purpose

This volume examines the endocannabinoid system in the equine hoof and whether cannabinoid-related pathways could eventually become research targets for laminitis.

The research in this area is extremely early. Researchers have identified biological changes in hoof tissue, but cannabinoids have not been clinically proven to treat laminitis.


Study 1: Endocannabinoid Receptors in the Equine Hoof

Distribution of Endocannabinoid System Receptors in the Equine Hoof: Dysregulation as a Potential Therapeutic Target for Laminitis

Published: 2025
Type: Equine tissue study
PubMed:
https://pubmed.ncbi.nlm.nih.gov/40593311/

What researchers examined

Researchers studied lamellar tissue from:

  • Healthy equine hooves
  • Hooves affected by laminitis

They examined receptors and cellular targets associated with the endocannabinoid system.

What researchers found

Endocannabinoid-system receptors were present within equine lamellar tissue. Their distribution or expression differed between healthy and laminitic tissue, suggesting that endocannabinoid signaling may be altered during laminitis.

Why this matters

Laminitis involves inflammation, cellular injury and failure of the structures connecting the hoof wall to the coffin bone.

Changes in endocannabinoid signaling may help researchers understand:

  • Inflammatory regulation
  • Pain signaling
  • Lamellar-cell survival
  • Tissue repair
  • Disease progression

What this does not prove

The study did not show that:

  • CBD prevents laminitis
  • THC treats laminitis
  • A topical balm reaches the hoof lamellae
  • Cannabinoids restore damaged lamellar attachments
  • Cannabis should replace emergency veterinary treatment

Responsible conclusion

The equine hoof contains components of the endocannabinoid system, and these components appear to become dysregulated during laminitis. This identifies a potential research target, not an established treatment.


Study 2: Cannabinoid-Related Targets in Equine Fibroblasts

Cannabinoid and Cannabinoid-Related Receptors in Fibroblasts Derived From Equine Tissues

Published: 2025
Type: Equine cell study

Why fibroblasts matter

Fibroblasts are cells involved in:

  • Producing connective tissue
  • Maintaining extracellular matrix
  • Responding to injury
  • Tissue repair and remodeling
  • Inflammatory signaling

Researchers identified cannabinoid and cannabinoid-related receptors in equine fibroblasts, adding evidence that the equine endocannabinoid system may influence tissue maintenance and healing pathways.

Important limitation

Cell studies show that a biological interaction is possible. They do not establish an effective treatment, dose, delivery method or clinical outcome in a living horse.


Current Status of Cannabinoids and Laminitis

What is supported

  • Equine lamellar tissue contains endocannabinoid-system receptors.
  • Receptor patterns may change in laminitis.
  • Endocannabinoid signaling may participate in inflammation and tissue regulation.

What remains unknown

  • Whether CBD or THC improves laminitis outcomes
  • Whether cannabinoids reduce hoof pain
  • Whether topical application can penetrate the hoof capsule
  • Whether cannabinoids affect insulin-associated laminitis
  • Whether cannabinoid treatment could interfere with other medications
  • What dose would be safe
  • Whether any treatment would improve coffin-bone stability or lamellar attachment

Evidence-based statement

Researchers have discovered endocannabinoid-system changes in laminitic equine hoof tissue. These findings may open new avenues for studying inflammation and healing, but no cannabinoid treatment has been clinically validated for laminitis.